anxiety

shutterstock_177126911

Introduction

Anxiety is something we can all relate to. For the most part, anxiety represents a healthy and adaptive physiological response to feared stimuli, preparing your body to respond accordingly. Perfect if you a™re being chased by a bear. However, it can be problematic if those feared stimuli are benign, no longer present, or constitute persistent worries about the future.

At it™s most debilitating, anxiety can be classified into a range of psychiatric diagnoses. The most common of these is generalised anxiety disorder (GAD), which has an estimated lifetime prevalence in the UK of between 4-7%. GAD is characterised by a range of physical symptoms such as muscle tension, poor concentration and disturbed sleep, as well as psychological symptoms such as ongoing and uncontrollable worry. Diagnoses such as panic disorder, social anxiety disorder and phobias all feature anxiety as a primary symptom. In total, anxiety-related difficulties have been estimated to affect as many as 18% of a US-based adult population over a 12-month period.

Though previously categorised as anxiety disorders, both obsessive compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are increasingly being understood as separate diagnoses, but again with anxiety as a common symptom.

What we know already

People with long-term physical health conditions are more prone to experience anxiety as a result. For example, it is estimated that people with Chronic Obstructive Pulmonary Disease (COPD) are up to 10 times more likely to receive a diagnosis of panic disorder than the general population. This, in turn, has considerable implications on healthcare expenditure.

Psychological treatments such a cognitive-behavioural therapy (CBT) have been widely researched and shown to be effective across a range of anxiety disorders. In the case of specific phobias, these techniques can elicit significant improvement in just one session. However, improvement rates are lower across other anxiety disorders.

In England, the National Institute for Health and Care Excellence (NICE) recommends CBT as the first line treatment of anxiety disorders. Pharmacotherapy, such as Sertraline, can also be beneficial, and is recommended as an adjunct to CBT where the person’™s difficulties are more severe.

Areas of uncertainty

Anxiety has been conceptualised in many ways, which in many ways have shaped the range of treatments available. This proliferation of cognitive, developmental, information-processing, neurochemical and other models of understanding anxiety can create a confusing picture. Similarly, whilst there is a clear hereditary component to anxiety, the precise nature is not yet clear.

Whilst psychological and pharmacological treatments can be effective for many, there is still work to be done in identifying the mechanisms of change and improving outcomes.

What’s in the pipeline?

Historically, research into anxiety disorders focused more heavily on adult populations. However, with the recent emergence of disciplines such as paediatric psychology, there is a greater emphasis on tackling anxiety difficulties at a younger age.

As our understanding of genetics improves, it is likely that we will discover more about the role of heritability in anxiety.

Perhaps, most importantly, given the effectiveness of treatments for anxiety, we should aim to reduce stigma and other barriers to access, to enable earlier intervention and better recovery.

References

Antony, M. M., and Stein, M. B. (2009). Oxford handbook of anxiety and related disorders. Oxford University Press. [Publisher]

Hoge, E. A., Ivkovic, A. and Fricchione, G. L. (2012). Generalized anxiety disorder: diagnosis and treatment. BMJ, 345. [Abstract]

Kesller, R. C., Ciu, W. T., Deler, O. and Walters, E. E. (2005). Prevalence, Severity, and Comorbidity of Twelve-month DSM-IV Disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 62, 617-627. [Abstract]

Naylor, C., Parsonage, M., McDaid, D., Knapp, M., Fossey, M. and Galea, A. (2012) Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund, London, UK. [PDF]

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Sep 2015
Review due: Sep 2016

Our anxiety Blogs

Social networking sites and mental health: friend or foe?

8464661409_4efdfbeae4_o

Una Foye and Josefien Breedvelt from the Mental Health Foundation publish their debut elf blog on a recent systematic narrative review that aimed to identify and summarise research examining depression and anxiety in the context of social networking websites.

[read the full story...]

Digital interventions for social anxiety disorder: new meta-analysis finds mixed results

5769222720_675ca3ce26_b

Carla McEnery reports on a recent meta-analysis of technology-assisted interventions for Social Anxiety Disorder, which finds positive results from Internet-delivered CBT and Virtual Reality Exposure Therapy.

[read the full story...]

Migrant mental health may improve with children’s educational success

6660141777_f3c5978a8e_b

John Moriarty’s debut blog investigates a recent cross-sectional study looking at whether the mental health of migrant parents is supported by the educational achievements of their children.

[read the full story...]

CBT for Autism Spectrum Disorders and comorbid mental illness

angry-1576878_6401

Alix Dixon presents a recent systematic review on the effectiveness of CBT for autism spectrum disorders and comorbid anxiety or depression.

[read the full story...]

Depression and coronary heart disease: reasons to remain UPBEAT-UK

7389091466_b428f08970_k

Kirsten Lawson summarises the UPBEAT-UK programme of research into the relationship between coronary heart disease and depression and anxiety in primary care patients.

[read the full story...]

Tooth extraction: factors affecting anxiety and fear

shutterstock_110356511

This review of factors affecting fear and anxiety in adult patients undergoing tooth extraction included 16 studies and identified a number of factors associated with anxiety although there are concerns over the quality of the available studies.

[read the full story...]

The case for investing in anxiety and depression treatment on a global scale

5556025283_6e385643dc_o

Chris Sampson looks at a major new economic study into the return on investment of increased coverage for anxiety and depression treatment.

[read the full story...]

Worried sick: cCBT and bibliotherapy for somatic symptom disorder and illness anxiety disorder

2920052762_9e3ff454a1_o

Suzanne Dash considers the findings of a recent RCT of exposure-based cognitive-behavioural therapy via the internet and as bibliotherapy for somatic symptom disorder and illness anxiety disorder.

[read the full story...]

Maternal anxiety disorders in the postnatal period: what do we know?

8641847152_d625b5f1f9_k

Janes Iles and Annette Eneberi summarise a recent systematic review and meta-analysis of current research evidence on anxiety disorders and their prevalence amongst postpartum women.

[read the full story...]